Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc. scores highest on Earnings (86) and lowest on Price (8). Its PosiPenta is 60.04 out of 100, better than most similar companies.
On the Penta Grid this week, Fennec Pharmaceuticals Inc. is Grid #145 of 837 in the Healthcare sector in United States, and Grid #623 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Fennec Pharmaceuticals Inc. | 60.04 | 8 | 86 | 77 | 77 | 53 |
| CapsoVision, Inc. | 40.57 | 2 | 63 | 42 | 34 | 62 |
| Capricor Therapeutics, Inc. | 38.82 | 33 | 39 | 27 | 36 | 60 |
| Kyverna Therapeutics, Inc. | 30.87 | 28 | 22 | 26 | 38 | 41 |
| Mobia Medical, Inc. | 42.85 | 33 | 32 | 32 | 59 | 58 |
| Relmada Therapeutics, Inc. | 50.03 | 32 | 56 | 42 | 67 | 54 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -83.17 |
| P/B ratio | 8.25 |
EEarnings
| Trailing EPS | ₹-11.37 |
| Forward EPS | ₹89.79 |
NNitro
| Price | 945.26 |
| 52-week high | 1254.97 |
| 52-week low | 535.14 |
| Fall from 52-week high | 24.7% |
TTorque
| Return on equity (ROE) | -18.58% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 1.23 |
| Market cap | ₹3,314 Cr |
| Insider holding | 14.17% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Fennec Pharmaceuticals Inc.'s PosiPenta score?
Fennec Pharmaceuticals Inc.'s PosiPenta is 60.04 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Fennec Pharmaceuticals Inc. stand on the Penta Grid?
On the Penta Grid this week, Fennec Pharmaceuticals Inc. is Grid #145 of 837 in the Healthcare sector in United States, and Grid #623 of 4,000 in United States.
Which PosiPenta pillar is strongest for Fennec Pharmaceuticals Inc.?
Earnings (growth), with a score of 86 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Fennec Pharmaceuticals Inc.?
Price (valuation), with a score of 8 out of 100: much weaker than most similar companies.
Has Fennec Pharmaceuticals Inc.'s PosiPenta changed since last week?
Yes, it rose 3.25 points, from 56.79 to 60.04.
PositoAI is for research and education only and is not investment advice.